Print Version

Home   News   Sports   Social   Obituaries   Events   Letters
Sheriff's officers now equipped with Narcan,
an opioid reversal agent
April 23, 2018
by Michael Meier
Director of Emergency Management
Public Information Officer
Boundary County, Idaho

The Boundary County Sheriff’s Office is equipping Patrol and Detention Deputies with Narcan Nasal Spray. The nasal spray is used to potentially save the life of anyone experiencing an opioid overdose. The Narcan Nasal spray and training were made possible through a grant offered by the Idaho Office of Drug Policy.

Opioids and Overdoses
Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.

Opioid pain relievers are generally safe when taken for a short time and as prescribed by a doctor, but because they produce euphoria in addition to pain relief, they can be misused (taken in a different way or in a larger quantity than prescribed, or taken without a doctor’s prescription). Regular use—even as prescribed by a doctor—can lead to dependence and, when misused, opioid pain relievers can lead to overdose incidents and deaths. An opioid overdose can possibly be reversed with Narcan Nasal Spray.

Narcan Nasal Spray
How does it work?

· Naloxone (the generic name for Narcan) temporarily reverses an opiate overdose by blocking the brain’s opiate receptors, potentially reversing some of the effects of the opioid drug.

· The duration of the effect varies, but typically lasts between 30 and 60 minutes. After the opiate receptors are no longer blocked by Naloxone, the individual may resume overdosing. It is important to call 911, even if it appears that the individual is no longer overdosing.

· Naloxone only temporarily reverses opiod overdoses.
Questions or comments about this article? Click here to e-mail!